Naveen Pemmaraju
Tracked across 1 events · 33 articles · First seen May 25, 2026 · Last active Jun 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Naveen Pemmaraju, MD, Professor at The University of Texas MD Anderson Cancer Center, presented new phase 2 tagraxofusp combination data in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
May 25, 2026 · 33 articles
ERGEN INTELLIGENCE
Track Naveen Pemmaraju live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard